Can methotrexate replace steroids for immunotherapy joint pain?

NCT ID NCT06001125

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested methotrexate, a common arthritis drug, for treating joint pain and swelling caused by cancer treatments that boost the immune system. The goal was to help patients stop taking steroids like prednisone, which have many side effects. The trial was stopped early after enrolling only 27 people, so we don't have clear answers on how well methotrexate works for this condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Methotrexate
What this could lead to
If it worked, methotrexate could offer an alternative to long-term steroids for managing joint pain from cancer immunotherapy, potentially reducing side effects.
What could go wrong
The trial was terminated early with only 27 participants, so results are limited. Methotrexate also has its own side effects and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHRALGIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cross Cancer Institute

    Edmonton, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.